Antisense Oligonucleotide Eye Drops
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Antisense Oligonucleotide Eye Drops, covering 2024-06-11 to 2024-06-11. Get the full timeline:
Most recent: Clinical Trial Update: Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis [EARLY_Phase 1]